Global dental equipment manufacturer Sifary Medical raises funds to expand its business
Changzhou Sifary Medical Technology Co., Ltd (Sifary Medical) (Chinese: 赛乐医疗) announced that it had completed over CNY 100 million in Series B funding round, which was led by GF Xinde Investment (Chinese: 广发信德) and followed by MoTianShi Investment (Chinese: 摩天石投资) and Youshuo Venture Partners (Chinese: 佑硕创投). HaoYue Capital (Chinese: 浩悦资本) acted as the exclusive financial adviser.
Proceeds raised in this funding round will be used to accelerate the promotion of present pipelines and expand businesses in high value medical consumable materials.
Founded in 2016, Sifary Medical (brand name Eighteeth) is the leading dental equipment platform in domestic market and has been committed to developing dental products, manufacturing, marketing and service integration for 6 years. Sifary Medical has more than 20 product categories including handpieces E-connect S, E-value, and E-xtreme, imaging systems HyperLight, Digital impressions Helios 600, dental irrigation product UltraClean and surgical loupes Brilliance, and owns 110 authorized patents. These products has been exported to more than 140 countries and served more than 100 thousand dentist clients. Affected by pandemic, Sifary Medical has also achieved double growth each year.
Sifary Medical's competitors include WoodPecker (Chinese: 啄木鸟医疗), Modern Dental Group (Chinese: 现代牙科), and Shining 3D (Chinese: 先临三维).